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Background: Insecticide-treated bed nets (ITNs) are the cornerstone of malaria control in sub-Saharan Africa but
their effectiveness may be compromised by the spread of pyrethroid resistance among malaria vectors. The
objective of this investigation was to assess the effectiveness of ITNs to prevent malaria in an area of Malawi with
moderate pyrethroid resistance.
Methods: One deltamethrin ITN was distributed in the study area for every two individuals in each household
plus one extra ITN for households with an odd number of residents. A fixed cohort of 1,199 children aged six to
59 months was seen monthly for one year and at sick visits to measure malaria infection and use of ITNs.
Insecticide resistance among malaria vectors was measured. The effect of ITN use on malaria incidence was
assessed, adjusting for potential confounders using generalized estimating equations accounting for repeated
measures.
Results: There were 1,909 infections with Plasmodium falciparum over 905 person-years at risk (PYAR), resulting in
an observed incidence of 2.1 infections per person-year (iPPY). ITNs were used during 97% of the PYAR. The main
vector was Anopheles funestus: mortality in WHO tube assays after exposure to 0.05% deltamethrin was 38% (95%
confidence interval (CI) 29–47), and resistance was due to elevated oxidase enzymes. After adjusting for potential
confounders, the incidence of malaria infection among ITN users was 1.7 iPPY (95% CI 1.5-2.1) and among non-bed
net users was 2.6 iPPY (95% CI 2.0-3.3). Use of ITNs reduced the incidence of malaria infection by 30% (rate ratio 0.7;
95% CI, 0.5-0.8) compared to no bed nets.
Conclusion: ITNs significantly reduced the incidence of malaria infection in children in an area with moderate
levels of pyrethroid resistance and considerable malaria transmission. This is the first study to show that ITNs
provide protection in areas where pyrethroid-resistant An. funestus is the major malaria vector. Malaria control
programmes should continue to distribute and promote ITNs in areas with low to moderate pyrethroid resistance;
however, insecticide resistance may intensify further and it is not known whether ITNs will remain effective at
higher levels of resistance. There is an urgent need to identify or develop new insecticides and technologies to limit
the vulnerability of ITNs to insecticide resistance.
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Bed nets have been used as a physical barrier to prevent
nuisance mosquito biting since the Sixth Century BC, but
were not used extensively for malaria control until after
pyrethroid insecticides were applied to net material in the
mid-1980s [1,2]. The combination of the insecticidal and
irritant effect of the pyrethroids with the physical barrier
of the bed net was found to reduce vector density, sporo-
zoite rates, malaria parasite prevalence, disease incidence,
and all-cause child mortality when evaluated both in clin-
ical trials [3] and as part of routine public health pro-
grammes [4] in areas where the principal malaria vectors
are largely endophagic (biting indoors) and endophilic
(resting indoors). As a result, insecticide-treated bed nets
(ITNs) are now the cornerstone of malaria prevention in
Africa [5]. The World Health Organization (WHO) esti-
mated that between 2010 and 2012, approximately 300
million ITNs were distributed in Africa, at a cost of more
than US$1 billion for their purchase and distribution [6].
Pyrethroids are currently the only class of insecticide
recommended for use on ITNs due to their low mamma-
lian toxicity and long residual activity [7]. Concern over
the potential impact of pyrethroid resistance on ITN
effectiveness was expressed early in the development of
ITNs for malaria control [8]. However, after manufactur-
ing processes were developed to mass produce long-
lasting ITNs, the potential risk from development of in-
secticide resistance was considered less important than
protecting as many people as possible with a ‘brilliant’ new
intervention [5]. As a result, household ITN ownership in-
creased from less than 5% of sub-Saharan African house-
holds in 2000 to almost 60% in 2012 [6].
Pyrethroid resistance was first reported in Anopheles
gambiae s.s. in West Africa in the early 1990s [9], and
was later detected in Anopheles funestus and implicated
in an epidemic of malaria in South Africa following the
switch from DDT to pyrethroids for indoor residual
spraying (IRS) [10]. Pyrethroid resistance in both vectors
has since spread throughout the continent [11], at least
partially as a result of widespread distribution of ITNs
[12]. Pyrethroid resistance in anopheline mosquitoes may
be due to target site resistance (point mutations that pre-
vent insecticide from binding with receptor molecules
on mosquito neurons); metabolic resistance (increased
level of one or more enzymes capable of detoxifying or
sequestering insecticides); or a combination of the two
mechanisms [11,13]. Resistant mosquitoes are not killed
or knocked down after contact with pyrethroid insecti-
cides. As a result, although ITNs might continue to pre-
vent blood feeding through the insecticide’s irritant
properties and the bed net’s physical barrier, the com-
munity effect, which is dependent on the ability of ITNs
to kill large numbers of adult mosquitoes, is likely to be
compromised.While there has been some limited evidence linking the
operational failure of pyrethroid-based IRS to resistant
vectors [14-16], there are as yet no epidemiologic data
demonstrating that pyrethroid resistance reduces the ef-
fectiveness of ITNs to prevent malaria infection. Several
studies of ITN efficacy or effectiveness conducted in
pyrethroid-resistant areas have shown continued ability of
ITNs to protect against malaria transmission when prop-
erly deployed [17-19]. A recent meta-analysis of entomo-
logic outcomes from experimental hut trials conducted in
areas with pyrethroid-resistant mosquitoes found that
ITNs continued to reduce blood feeding and increase
mosquito mortality compared to untreated bed nets, even
in the areas with the highest levels of resistance [20]. How-
ever, the resistance profiling of the mosquitoes in these
studies was inadequate, leaving significant uncertainties as
to the resistance mechanisms responsible and thus limit-
ing conclusions.
Malaria remains a significant problem in Malawi,
where the entire population is at risk and it was esti-
mated that 48% of the population resides in areas where
the age standardized Plasmodium falciparum prevalence
in children aged two to ten years is 40-50% [21] and
more than 6.7 million clinical malaria cases occurred in
2010 [22]. The Malawi National Malaria Control Strat-
egy 2011–2015 allocates almost one-third of its total
five-year budget to prevention of malaria transmission
through ITNs [23]. Since 2009, more than 20 million
ITNs have been distributed in the country through mass
campaigns as well as routine mechanisms such as ante-
natal and well-child clinics. As a result, household own-
ership of at least one ITN increased from 27% in 2004
to 55% in 2012, and use of ITNs by children less than
five years old the night before the survey increased from
<5% in 2000 to over 55% in 2012 [22].
WHO phenotypic resistance assays conducted in
Malawi in 2007 found both major malaria vectors (An.
funestus and An. gambiae s.l.) to be susceptible to all in-
secticides, including pyrethroids. Within three years,
however, anopheline resistance to pyrethroids could be
found in eight of 11 sites examined down the length of
the country [24]. The frequency of resistance was higher
in An. funestus than An. gambiae s.l.; biochemical assays
demonstrated that the resistance mechanism was meta-
bolically based for both species.
National malaria parasite prevalence in children less
than five years in Malawi fell in 2012 to 28% from 43%
in 2010 [25,26].However, prior to the encouraging 2012
results, several reports suggested that national scale-up
of control activities had failed to substantially change the
malaria burden in the country [21,27], and pyrethroid
resistance was mentioned as a possible threat to success-
ful malaria control [24]. Given the important role for
ITNs in the Malawi national malaria control strategy, an
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reducing malaria incidence among a cohort of children




The study was conducted in the Traditional Authority of
Sitola in Machinga District, surrounding the town of
Liwonde (500 m above sea level; −15°3'S 35°14'E). The
study area is bordered on the west by the Shire River
and on the northeast by the Likwenu River and Liwonde
National Park (Figure 1). The population of the area is
mostly of the Yao ethnic group, but both Chichewa and
Chiyao are spoken. Annual rainfall is unimodal and ap-
proximately 1,000 mm falls between October and May,
with daily temperature averaging 26°C in the rainy season
and 21°C in the dry season. In this area, malaria trans-
mission is intense and perennial, peaking during the
rainy season. Entomological monitoring in Machinga
District by the Malaria Alert Centre of the Malawi Col-
lege of Medicine (Blantyre, Malawi) prior to the start of
the study found a moderate level of pyrethroid resist-
ance of An. funestus to 0.05% deltamethrin (38% mortal-
ity, 95% confidence interval (CI) 28–49) (TM, pers
comm). This area has never received indoor residual
spraying for malaria control.
Study design and population
The incidence of malaria infection was compared be-
tween users and non-users of ITNs in a fixed cohort of
children aged six to 59 months who were followed for
12 months after they were cleared of infection with
artemether-lumefantrine. Preliminary household map-
ping was conducted in late 2011 and the six villages
closest to Liwonde town, but excluding the urban area
itself, were selected for inclusion. Households in these
villages were geocoded in February and March 2012 and
all children six to 59 months old were invited to participate
in the survey, with some households contributing more
than one eligible child. Incident cases of malaria infection
were identified through a combination of active (routine
monthly visits) and passive (sick visits) surveillance.
ITN distribution
The initial household census was used to determine the
number of ITNs needed per house by allocating one ITN
per two household residents plus one extra for households
with odd numbers of residents. The long-lasting bed nets
distributed were Permanet 2.0 (Vestergaard, Lausanne,
Switzerland), treated with deltamethrin, and a total of
5,146 ITNs were distributed to household heads during
the month of May 2012. The allocation algorithm used in
the area was the same as that used by the National MalariaControl Programme in the national ITN distribution that
took place in July 2012 (JZ, pers comm).Sample size determination
The sample size was based on a generalized estimating
equations modelling approach with a Poisson distribu-
tion and accounted for the correlated nature of repeated
measurements on study children using an exchangeable
correlation structure [28]. The incidence among children
who did not use ITNs (projected to be 30% of the popu-
lation after the ITN distribution) was estimated to be 1.0
episodes per child-year, and the power to detect a 30%
reduction in incidence among those using ITNs (pro-
jected to be 70% of the population after ITN distribu-
tion) was set at 70%, with the probability of committing
a Type 1 error equal to 5%. The resulting calculation
yielded 684 ITN users and 297 non-ITN users for a total
of 981 children. Assuming a 5% refusal rate, 15% loss-
to-follow-up over 12 months, and a mortality rate of
1.5% per year resulted in a total of 1,335 children to be
enrolled at baseline. Under the assumption that in the
study area, 60% of households had at least one child
aged six to 59 months, a total of 2,225 households would
be needed. As 2,300 households were mapped in the
study area, all age-eligible children were invited to par-
ticipate in the cohort study.Enrolment and monthly visits
Children were eligible to participate if they were be-
tween six and 59 months as of 1 March, 2012, not taking
daily cotrimoxazole for HIV infection or exposure,
weighed 5 kg or more and planned to stay in the study
area for at least one month.
At enrolment and all monthly visits, children and their
caregivers were invited to a central location near their
home; no reimbursement or incentive was provided to
caregivers to attend the routine monthly visits. At enrol-
ment and the tenth monthly visit, children had their
height and weight measured. At each monthly visit, axil-
lary temperature was measured and a finger stick was
performed to collect a blood sample for thick and thin
blood smears and haemoglobin (Hb) measurement using
a Hemocue® (Angelholm, Sweden) portable haemoglo-
binometer. At enrolment, a dried blood spot was also
made for Plasmodium testing by nested polymerase
chain reaction (PCR) at the Malawi College of Medicine
in Blantyre [29]. All samples collected at enrolment were
tested for the presence of P. falciparum, Plasmodium
malariae, Plasmodium ovale, and Plasmodium vivax. At
monthly visits, malaria testing was conducted using a
histidine-rich protein 2 (HRP-2) P. falciparum malaria
rapid diagnostic test (RDT; SD Bioline Malaria Ag Pf®
ref. 05FK53, Kyonggi-do, Republic of Korea).
Figure 1 Map of the study area, Liwonde, Malawi.
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givers were questioned regarding the child’s two-week ill-
ness history, household bed net ownership and bed net
use. Bed net use by the child was referenced for the night
before the survey, the two-week period before the survey
and for typical use during the current season. Study ITNs
were not distributed until after enrolment in May 2012,
and many residents retained their older bed nets. There-
fore, the age of the bed net used by the child was requested
along with the caregiver’s assessment of the condition
(presence/absence of holes, the number of holes larger than
a fist and the number larger than a head).
At enrolment, all children were provided with a full, weight-
appropriate treatment course of dispersible artemether-
lumefantrine (Coartem®-D, Novartis, Basel, Switzerland);
the first dose was observed by study staff, and parents
or caregivers were instructed on how and when to give
the remaining doses. At subsequent visits, only children
with positive RDT results were treated with an appropriate
anti-malarial.
Study staff attempted to contact any child who did not
attend the monthly visit to schedule a make-up visit.
Any child who did not attend three consecutive visits for
any reason was withdrawn from the study and censored
as of their last visit date.
Sick visits
During the study period, caregivers were encouraged
to bring participants to the study clinic located at
Machinga District Hospital, the only health care facility
within 30 km of Liwonde Town, if they became sick.
Artemisinin-based combination therapy is free at public
health facilities, and 91% of children under five years of
age with fever in the two weeks before the Malawi Mal-
aria Indicator Survey in 2012 and treated with an anti-
malarial received an artemisinin-based combination
therapy, suggesting limited use of private physicians and
drug shops [26]. Sick children were examined by a study
clinician who measured axillary temperature and took a
finger-prick blood sample for malaria testing using a
RDT, and Hb testing with a Hemocue®. The same ques-
tionnaire used at enrolment and the monthly visits was
employed to elicit a two-week period illness history and
bed net use from the child’s caregiver. Caregivers were
reimbursed for transport to the study clinic for one sick
visit per month.
Confirmation of ITN use
The reliability of caregiver-reported ITN use was evaluated
twice during the study period (JW, pers comm). Briefly,
children attending monthly visits between December 2012
and January 2013 and September and October 2013 were
randomly selected for follow-up home visits, which oc-
curred between zero and eight days after the monthly visit.Caregiver responses to questions about ITN use at the
monthly visits were compared to the same questions asked
at the home visit plus visual inspection of the ITN reported
to be used by the child. The proportion of positive and
negative agreement of ITN use between caregiver report
and home visit were calculated and 95% CI were con-
structed using bootstrapping.
Entomologic surveillance and resistance monitoring
The study area was divided into ten clusters and every
two weeks pyrethroid spray catches (PSCs) were con-
ducted in ten houses per cluster using standard methods
[30]. Sexing and morphologic species identification was
conducted in the laboratory at the Malaria Alert Centre.
Anopheles funestus and An. gambiae s.l. mosquitoes were
tested for the presence of sporozoites in their salivary
glands using standard procedures [31]. Phenotypic pyreth-
roid resistance was evaluated in the study area during the
course of the study using the standard WHO tube assay
with two to five days old An. funestus and An. gambiae s.l.
reared from eggs or larvae [32].
To determine whether the mechanism of resistance was
an elevated oxidase or esterase enzyme, mosquitoes were
pre-exposed to the synergist, piperonyl butoxide (PBO),
for one hour before the WHO tube assay was conducted.
Synergists are non-toxic to insects but improve the effect
of an insecticide by inhibiting the metabolic enzymes (oxi-
dases and esterases) that cause mosquitoes to be resistant.
Mosquitoes were exposed to PBO in 250 ml Wheaton bot-
tles. The bottles were coated by adding 1 ml of a stock so-
lution of 400 mg/L of PBO (corresponding to a dose of
400 ml/bottle) in acetone, rotating the bottles to ensure all
surfaces were covered and then allowing the acetone to
evaporate. Two to five days old female mosquitoes were
added to the bottle and exposed for one hour. The mos-
quitoes were then removed and exposed to 0.05% delta-
methrin or 0.75% permethrin in WHO tube assays as
described above [33].
Assays were performed to detect mutations in the knock-
down resistance (kdr) locus using either a leg or wing re-
moved from the mosquito corpse of mosquitoes for which
species identification was confirmed molecularly. Stratified
samples of mosquitoes of both species determined by the
WHO resistance assay to be resistant or susceptible to
permethrin or deltamethrin were randomly selected for
testing for commonly reported kdr mutations. Two dif-
ferent assays were utilized depending on the species
being tested: Huynh et al. for An. gambiae s.l. and Mor-
gan et al. for An. funestus [34,35]. All assays were per-
formed without modification and PCR amplicons were
visualized on a 1.5% 0.5X tris-borate-EDTA agarose gel
stained with ethidium bromide and visualized in a Gel
Doc-It2 UV imager (UVP LLC, Upland, CA, USA). Fur-
ther sequencing was done on An. funestus samples to
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ated with resistant populations were present within the
amplified region. Samples were processed using BigDye®
Terminator v3.1 (Life Technologies, Grand Island, NY,
USA), purified with BigDye® XTerminator and sequenced
on an ABI 3500 sequencer (Applied Biosystems, Foster
City, CA, USA). Sequences were aligned using Lasergene®
SeqMan (DNASTAR, Madison, WI, USA) and confirmed
using the basic local alignment search tool feature.
The WHO definition considers insecticide resistance
to be confirmed when mortality of mosquitoes exposed
to insecticides in bioassays is <90% [32]. The level of re-
sistance was classified according to Strode et al. [20].
Mosquitoes of both species (An. funestus and An. gam-
biae s.l.) were selected from the mosquitoes alive or killed
by the resistance bioassay and tested using PCR to deter-
mine the sibling species. Mosquitoes of the An. gambiae
complex were identified using the methods described by
Wilkins et al. [36] while members of the An. funestus
group were identified using a modification of the protocol
described by Koekemoer et al. with intentional mis-
matched primers [37,38]. For An. funestus, specimens were
tested with primers for An. funestus s.s., Anopheles vanee-
deni, Anopheles rivulorum, An. rivulorum-like, Anopheles
parensis, and Anopheles leesoni. Anopheles gambiae s.l.
were tested with primers for An. gambiae s.s., Anopheles
arabiensis, Anopheles coluzzii, Anopheles quadriannulatus
(species A) and Anopheles melas/merus. Mosquitoes that
did not amplify against one of these primers were retested
with universal primers for the internal transcribed spacer 2
region to determine whether the lack of amplification was
due to poor specimen preservation.
Data management and analysis
The main outcome was P. falciparum parasitaemia at a
sick or monthly visit as measured by RDT. The main ex-
posure variable was bed net use the night before the
visit, categorized as ITN, untreated bed net (UTN) or no
bed net. Bed nets used between enrolment and the end
of the ITN distribution were classified as a UTN if they
were reported to be 36 months or older; however, as of
1 June, 2012, after ITNs were distributed by the project,
no bed nets were considered to be untreated. Children
were described as anaemic (Hb <11 g/dl) or not anaemic
(Hb ≥11 g/dl).
A number of potential confounders was measured and
included in the analysis. Baseline parasitaemia was mea-
sured by PCR and used to indicate previous exposure to
malaria infection. A proxy measure of individual exposure
to malaria transmission was generated by using the inverse
distance-weighted (IDW) malaria prevalence in children
within 1 km, divided into terciles [39]. Household altitude
was divided into terciles. Household ownership of key as-
sets was analysed using principal component analysis andthe coefficient of the first component was used to generate
a household asset score [40]. Assets included electricity,
paraffin lamp, battery lamp radio, television, cell phone,
mattress, sofa set, table and chairs, refrigerator, bicycle,
motorcycle, car, source of water, type of toilet, type of floor
material, type of roof material, type of wall material and
number of sleeping rooms. Children were divided into ter-
ciles according to their household’s asset score. Stunting
(height-for-age) and wasting (weight-for-age) were defined
as Z-scores < −2 compared to the WHO growth reference
charts by age and sex [41]. Children were remeasured in
the tenth month of the survey and their nutritional status
was allowed to change. Because of the potential for the
density of ITNs around a participant to create a mass ef-
fect, participants were divided into terciles based on the
total number of ITNs found in households within 300 m;
this radius was based on data from a cluster-randomized
trial of ITNs in western Kenya that found a mass effect
within 300 m [42]. Data on household ITN ownership
from the household mapping exercise before the start of
the study were used to calculate ITN density for partici-
pants between enrolment and the time of the ITN distri-
bution. After the ITN distribution was completed, a new
density calculation was made assuming the number of
ITNs per household matched the distribution algorithm of
one ITN per every two household residents with one extra
for households with an odd number of residents. The sea-
sonality of malaria transmission was accounted for by
dummy variables indicating visits during the high (April-
June 2012 and January-March 2013) or low (July-Decem-
ber 2012) malaria transmission season.
Data from monthly and sick visits were combined into
one dataset and time between visits was calculated as
person-time at risk. After every positive result treated with
artemether-lumefantrine, including the baseline treatment
dose, 10.5 days were subtracted from the person-time at
risk to account for the half-life of lumefantrine [43].
As febrile children who came for sick visits in between
monthly visits would have been tested again for malaria
with an RDT, there was the potential that the second of
sequentially positive RDTs was a false positive due to per-
sistent antigen from a recently treated infection. Follow-
up of infected children after malaria treatment in Uganda
found that the median duration of persistent antigenaemia
using HRP2-based RDTs was 35 days (95% CI 33–37), al-
though the possibility of re-infection could not be ruled
out [44]. A mathematical model of HRP2 antigenaemia
found that persisting antigen caused tests to remain posi-
tive for up to seven days after treatment, depending on the
length and density of infection before treatment [45]. In
this study, there were 972 pairs of sequential visits (out of
a total of 13,166 visits) in children with positive RDT re-
sults. The median time between these paired, positive se-
quential visits was 17 days. To attempt to minimize the
Figure 2 Study profile, Liwonde, Malawi 2012–2013.
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positive, second visits > =17 days were considered new
infections, whereas second visits with a positive RDT
that occurred <17 days after an earlier positive visit
were considered false positives. Recognizing that there
is no clear cut-off to determine whether a second posi-
tive RDT was due to a new infection or persistent anti-
genaemia, a sensitivity analysis was conducted by
varying the cut-off +/−one week in either direction, i.e.,
cut-offs of 10 and 24 days.
SAS® (v. 9.3, SAS Institute, Inc., Cary, NC, USA) was
used for all analyses. Data were analysed using Poisson
regression with a generalized estimating equations ap-
proach (PROC GENMOD) to account for the extra cor-
relation from repeated measures on the same child [46].
Both the exposure variable and covariates were allowed
to be time varying. Log-transformed person-time was used
as an offset and an exchangeable working correlation
structure was specified. Any covariate with a p-value of
>0.1 in univariate analysis was included in the multivariate
model. Rate ratios (RR) and 95% CI were calculated from
model parameters and model-adjusted incidence rates for
covariates are presented. Protective effectiveness (PE) was
calculated as 100%*(1-R1/R0) where R1 is the rate among
ITN or UTN users and R0 is the rate among non-bed net
users. The attributable rate difference was calculated as
R1-R0 and interpreted as the number of malaria infections
prevented by ITNs annually.
Human subjects
Household heads provided verbal consent to have their
household mapped and residents enumerated. Parents or
caregivers provided verbal consent to have their child
screened for eligibility, and read and signed written in-
formed consent forms if the child was found to be eligible.
Households selected for PSCs provided verbal consent.
The protocol was reviewed and approved by the Malawi
College of Medicine Research Ethics Committee (Blantyre,
Malawi) and by the US Centers for Disease Control and
Prevention institutional review board (Atlanta, GA, USA).
Results
Study profile and baseline characteristics
There were 2,804 houses in the study area, and 2,178
(78%) agreed to be mapped and enumerated (Figure 2). A
total of 1,665 children between six and 59 months old
were registered and 1,199 (72%) enrolled from 907 house-
holds. There were 268 (29%) households with more than
one child enrolled. A total of 175 (10%) children could not
be located during the enrolment period or were found to
have moved out of the study area; 201 (12%) children de-
clined to participate, and 90 (5%) were found to be ineli-
gible. Comparing the enrolled children with those who
declined to participate or could not be located, males(78%) were more likely to be enrolled than females (74%;
Chi square test p = 0.04), but those enrolled had a similar
median age (30 months) to those not enrolled (29 months;
Wilcoxon signed-rank test p = 0.80). There was no signifi-
cant difference in enrolment between children who re-
ported sleeping under a bed net (76%) and those who did
not (73%; Chi square test p = 0.26).
Median follow-up time of the cohort of 1,199 children
was 0.96 years (interquartile range (IQR) 0.92, 0.97) and
1,018 (85%) children completed one year of follow-up
(Table 1). Reasons for early exit from the cohort in-
cluded: consent withdrawn or child moved out of the
study area (n = 145, 12%), started cotrimoxazole therapy
(n = 3, 0.2%), died (n = 2, 0.2%), and could not be traced
Table 1 Descriptive characteristics of the study cohort,
Liwonde, Malawi 2012-2013
Characteristic Results
Number of children enrolled 1,199
Number of households included 907
Median age at enrolment in months (IQR)* 30 (17, 44)
Number of children who completed one
year follow-up, n (%)
1,018 (85)
Person-years at risk 905
Female, n (%) 579 (48)
Plasmodium infection at baseline (PCR), n/N (%)* 440/1,192 (37)
Median IDW malaria prevalence <1 km (IQR)* 35% (24, 48)
Anaemic (Hb <11 g/dl), n (%) 860 (72)
Caregiver completed primary school, n (%) 215 (18)
Bed net used, n/N (%) 922/1,175 (78)
ITN used, n/N (%) 516/1,174 (44)
ITN has ≥1 hole fist-sized or larger, n/N (%) 110/404 (21)
Median number of ITNs within 300 m (IQR)
Baseline 8 (5, 21)
After ITN distribution 48 (27, 116)
Malaria infections** 1,909
Median malaria incidence per person-year (IQR) 1.2 (0, 3.6)
*IQR = Interquartile range; PCR = polymerase chain reaction; IDW = inverse
distance-weighted; Hb = haemoglobin; PPY = per person year.
**As measured by malaria rapid diagnostic tests.
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the study and the time at risk for the whole cohort was
905 person-years (after removing non-risk periods due to
anti-malarial treatment). Attendance at monthly visits var-
ied between 90% in May 2012 and 74% in December 2012;
at least one sick visit was made by 67% (n = 803) of the
participants, and the median number of sick visits among
them was 2 (IQR 1, 4).
Slightly less than half (48%) of the enrolled children
were female (Table 1). At baseline, 37% of children were
infected with malaria as confirmed by PCR, the majority
(97%) with P. falciparum, and the remainder with
P. malariae and P. ovale. The median IDW prevalence
of malaria in children within 1 km was 35% (IQR 24,
48). The median Hb measurement was 10.0 g/dl (IQR
8.7, 11.1) and 72% of children were anaemic. A third of
children (32%) were stunted and 3% met the definition
of wasted. Less than one-fifth (18%) of the caregivers
had completed primary school.
At baseline, bed net use the night before the survey
was reported for 78% of children, but only 44% were re-
ported to have used an ITN. Use of an ITN the night be-
fore the survey was strongly associated with use of an
ITN over the previous fortnight: 97% of those who used
an ITN the night before the survey had used an ITNevery night out of the previous 14 nights and the re-
mainder had used an ITN at least once in the last two
weeks. Among those reporting not using an ITN the
night before the survey, 99% reported not using an ITN
at all during the previous 14 nights. A large proportion
(59%) of the ITNs were reported to have holes, with
one-fifth (21%) reported to have at least one hole fist-
sized or greater. The median number of ITNs within
300 m of participants at baseline was 8 (IQR 5, 21).
Malaria incidence
Between April 2012 and March 2013 there were 1,909
infections with P. falciparum identified, most (65%)
through active surveillance at monthly visits (Table 1).
The median incidence per child was 1.2 infections per
person-year (iPPY) (IQR 0, 3.6), and the overall inci-
dence was 2.1 iPPY. A third of the children (32%) never
had documented malaria infection during the study,
whereas 44% had two or more infections. During the
study period, which crossed two rainy seasons, there
were two peaks of transmission corresponding to the
end of the 2012 rainy season (May 2012) and the last
month of the 2013 rainy season included in the study
survey (March 2013; Figure 3).
Use of ITNs over time
Information on child’s ITN use was recorded for 895
person-years at risk (PYAR), and ITN use the night be-
fore the survey was reported for 864 (97%) PYAR, UTN
use for 17 (2%) PYAR and no bed net for 15 (2%) PYAR.
To measure the reliability of caregiver-reported ITN use
at the routine monthly surveys, study staff visited 211
randomly selected children from December 2012-
January 2013 and 325 children between September and
October 2013 (JW, pers comm). The observed propor-
tions of positive agreement between caregiver report and
home visit on ITN use by the child in the first and sec-
ond surveys were 98.8% (95% CI 97.6-99.8) and 93.3%
(95% CI 91.2-95.3), respectively. The proportions of
negative agreement in the first and second survey were
28.6% (95% CI 0–75) and 20.0% (95% CI 0.1-35.0).
Entomologic surveillance and resistance monitoring
There were 885 female anophelines collected through
PSC; 743 (84%) were identified as An. funestus Giles and
142 (16%) as An. gambiae s.l. Mean indoor resting density
for both species was highest in April 2012 and again be-
tween December 2012 and March 2013 (Figure 4). A total
of 711 of the An. funestus and 114 of the An. gambiae s.l.
collected by PSCs were tested for sporozoites and 30 (4%)
and two (2%) were positive, respectively.
Results of the phenotypic resistance assays are shown
in Table 2. Mortality of An. funestus after exposure to
0.05% deltamethrin and 0.75% permethrin was 38 and
Figure 3 Monthly incidence of malaria infection in a fixed cohort of children age six to 59 months at baseline and monthly rainfall,
Liwonde, Malawi 2012–2013. Error bars indicate the standard error of the rate.
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mortality rates with these insecticides rose to 89 and
98%, respectively. Mortality of An. gambiae s.l. to 0.05%
deltamethrin and 0.75% permethrin was 53 and 65%,
and exposure to PBO increased mortality from 0.75%
permethrin to 100%. No testing of An. gambiae s.l. to
0.05% deltamethrin after PBO exposure was conducted
due to low numbers of mosquitoes. Taken together, the
results of increased pyrethroid susceptibility after expos-
ure to PBO implicate elevated oxidase enzymes as the
primary resistance mechanism.
Of the 22 An. gambiae s.l. tested, none possessed either
of the two kdr-like mutations L1014F (West African kdr)
or L1014S (East African kdr) reported in An. gambiae s.s.
Of the 20 An. funestus samples chosen for additional se-
quencing, seven resistant and eight susceptible samples
yielded complete sequences. Based on alignments with
the An. funestus FUMOZ laboratory colony, which origi-
nates from Mozambique and does not possess kdr, none
had any single nucleotide polymorphisms that were
unique to either the resistant or susceptible populations.In summary, neither vector species showed evidence for
the presence of kdr genes.
There were 23 An. funestus s.l. identified to species
out of 100 that survived exposure to pyrethroids, and 12
tested out of 39 that were killed by exposure to pyreth-
roid and all (100%) were found to be An. funestus s.s.
There were 17 An. gambiae s.l. tested that survived the
pyrethroid exposure and 22 that did not, and 16 and 22,
respectively, were identified to species; 100% of the sur-
viving mosquitoes and 95% (21/22) of the killed mosqui-
toes were found to be An. arabiensis. One (5%) of the
killed mosquitoes was identified as An. gambiae s.s.
Bed nets and malaria incidence
In univariate analysis, children between six and 11 months
old experienced twice the malaria incidence than those
older than 12 months; malaria infection at baseline was
also associated with almost twice the malaria incidence of
those without infection at baseline (Table 3). Use of ITNs,
but not UTNs, was associated with a 60% reduction in the
incidence of malaria compared to children who did not
Figure 4 Indoor resting density of malaria vectors in Liwonde, Malawi, 2012–2013. Error bars indicate the standard error of the mean,
accounting for the sampling design.
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had not completed primary school had higher rates of
malaria. Children living at the lowest altitudes had a 40-
60% increase in malaria incidence compared to those at
the highest elevations. Children living in households with
the lowest numbers of ITNs within 300 m experienced al-
most twice the incidence of malaria than children living
with the highest ITN density, whereas the children living
with the lowest IDW malaria prevalence within 1 km ex-
perienced 20-40% reductions in malaria incidence. MalariaTable 2 Results of resistance testing using the WHO tube assa






An. funestus Deltamethrin 0.05% 38 (29
Permethrin 0.75% 25 (8–
An. gambiae s.l. Deltamethrin 0.05% 53 (24
Permethrin 0.75% 57 (32
a Mosquitoes with and without pre-exposure to PBO for one hour before resistance
b 95% confidence intervals calculated taking clustering by tube into account.incidence was highest after the rains from April to June
2012, with an incidence of 4.1 iPPY, and lowest during the
dry season from July to December 2012, with an incidence
of 0.9 iPPY.
After controlling for all variables significantly associated
with malaria incidence in univariate analyses, use of an
ITN was associated with a protective effectiveness of 30%
(RR 0.7, 95% CI 0.5-0.8; Table 3). UTNs were not statisti-
cally associated with malaria incidence (RR 0.8, 95% CI
0.6-1.0). Results were not sensitive to the time period usedy with two to five days old mosquitoes with and without
ut pre-exposure to PBOa With pre-exposure to PBO
rtality (95% CI)b % mortality (95% CI)
ied/tested) (No. died/tested)
–47) (58/152) 89 (37–100) (34/38)
42) (23/93) 98 (93–100) (89/91)
–81) (49/93)
–82) (65/114) 100 (90–100) (27/27)
testing using the WHO tube assay.


















Age (months) 6-11 64 17 3.7 (2.7-5.0) 2.2 (1.6-3.0) <0.0001 2.1 (1.5-2.9) 1.0 (0.8-1.4) 0.84
12+ 1845 891 1.7 (1.6-1.8) 1.0 2.0 (1.8-2.3) 1.0
Sex Female 905 433 1.7 (1.6-1.9) 1.0 (0.9-1.1) 0.96
Male 1004 471 1.7 (1.6-1.9) 1.0
Baseline Plasmodium
infection
Positive 948 329 2.4 (2.2-2.7) 1.7 (1.5-2.0) <0.0001 2.7 (2.2-3.3) 1.7 (1.5-1.9) <0.0001
Negative 960 573 1.4 (1.3-1.5) 1.0 1.6 (1.3-2.0) 1.0
Bed net use ITN 1710 864 1.6 (1.5-1.7) 0.4 (0.3-0.5) <0.0001 1.7 (1.5-2.1) 0.7 (0.5-0.8) <0.0001
UTN 92 17 4.9 (4.1-5.9) 1.1 (0.8-1.5) 0.53 2.0 (1.6-2.6) 0.8 (0.6-1.0) 0.06
No bed net 86 15 4.4 (3.5-5.7) 1.0 2.6 (2.0-3.3) 1.0
Wealth index Poorest 725 290 2.1 (1.9-2.3) 1.5 (1.3-1.8) <0.0001 2.3 (1.9-2.8) 1.3 (1.1-1.5) 0.0008
Middle 647 296 1.8 (1.6-2.0) 1.3 (1.1-1.6) 0.001 2.2 (1.8-2.7) 1.2 (1.1-1.5) 0.01
Least poor 495 309 1.4 (1.2-1.6) 1.0 1.8 (1.4-2.2) 1.0
Caregiver completed
primary
Yes 239 164 1.2 (0.9-1.4) 0.6 (0.5-0.8) <0.0001 1.9 (1.5-2.4) 0.8 (0.7-1.0) 0.02
No 1628 730 1.9 (1.7-2.0) 1.0 2.3 (1.9-2.8) 1.0
Altitude Lowest 680 300 1.9 (1.7-2.1) 1.4 (1.2-1.7) 0.0001 2.4 (1.9-2.9) 1.5 (1.3-1.8) <0.0001
Middle 727 294 2.1 (1.9-2.4) 1.6 (1.3-1.9) <0.0001 2.4 (2.0-2.9) 1.5 (1.3-1.8) <0.0001
Highest 497 307 1.3 (1.2-1.5) 1.0 1. (1.3-2.0) 1.0
Number of ITNs <300 m Lowest 586 249 2.0 (1.8-2.3) 1.7 (1.4-2.1) <0.0001 2.1 (1.7-2.6) 1.1 (0.9-1.4) 0.39
Middle 737 313 2.1 (1.9-2.3) 1.7 (1.5-2.1) <0.0001 2.2 (1.8-2.7) 1.2 (0.9-1.4) 0.17
Highest 389 272 1.2 (1.0-1.4) 1.0 1.9 (1.5-2.4) 1.0
IDW malaria prevalence Lowest 474 294 1.3 (1.1-1.5) 0.6 (0.5-0.7) <0.0001 1.7 (1.3-2.1) 0.7 (0.5-0.8) 0.0002
Middle 610 304 1.7 (1.5-1.9) 0.8 (0.6-0.9) 0.0003 2.2 (1.7-2.7) 0.9 (0.7-1.0) 0.04
Highest 820 302 2.3 (2.1-2.5) 1.0 2.5 (2.1-3.1) 1.0
Season Apr-June 844 178 4.1 (3.8-4.4) 2.3 (2.0-2.7) <0.0001 4.6 (3.9-5.5) 2.3 (2.0-2.6) <0.0001
July-Dec 556 486 0.9 (0.8-1.0) 0.5 (0.4-0.6) <0.0001 1.0 (0.8-1.2) 0.5 (0.4-0.6) <0.0001
Jan-Mar 509 241 1.8 (1.6-2.0) 1.0 2.0 (1.6-2.5) 1.0
a PPY = per person year; IDW = inverse distance-weighted; ITN = insecticide-treated bed net; UTN = untreated bed net; CI = confidence interval.
b Incidence is model-adjusted for all other variables in the column.
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positive RDT results was considered a new infection: with
a cut-off of 10 days, use of an ITN was associated with a
30% reduction in malaria incidence (RR 0.7, 95% CI 0.5-
0.9), whereas a cut-off of 24 days resulted in a 40% reduc-
tion (RR 0.6, 95% CI 0.5-0.7).
The model-adjusted incidence of malaria among ITN
users was 1.7 iPPY (95% CI 1.5-2.1) and among UTN
users was 2.0 iPPY (95% CI 1.6-2.6), whereas among chil-
dren who did not use any bed net, the model-adjusted in-
cidence was 2.6 iPPY (95% CI 2.0-3.3). The attributable
rate difference for ITNs (subtracting the incidence rate
among those who used ITNs from the incidence rate of
those who did not, i.e. 2.6-1.7 iPPY) was 0.9 malaria infec-
tions averted per person-year, or 815 malaria infections
averted in the study population. Therefore, for every tenchildren protected by ITNs, nine malaria infections were
prevented annually.
Discussion
ITNs were found to reduce the incidence of malaria by
30% among children six to 59 months old in an area of
Malawi where deltamethrin killed only 38% of An. funes-
tus, the main malaria vector, and 53% of An. gambiae s.l.,
the secondary vector, in WHO tube assays. Prior to the
continent-wide increase in pyrethroid resistance, random-
ized controlled trials of the efficacy of ITNs compared to
no bed nets in areas with similar malaria incidence to
Malawi showed ≥50% reductions in the incidence of
malaria [47-49]. It is possible, therefore, that in the ab-
sence of pyrethroid resistance, ITN effectiveness might
have been higher in this population. However, the lower
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als also could be due to factors related to the study design
(e.g., observational cohort vs randomized controlled trial)
and analytical methods. Additionally, the high rate of ITN
use in this population may have suppressed transmission,
benefitting non-bed net users and reducing differences be-
tween users and non-users of ITNs.
ITNs prevent malaria through several modes of action:
the insecticide deters mosquitoes from entering houses,
irritates the mosquitoes that encounter the insecticide,
causing them to leave the area prematurely, and kills the
mosquitoes that acquire a lethal dose. In addition, ITNs
provide a physical barrier to blood feeding. This latter
mode of action is the only one that does not depend on
the insecticide, and potentially could account for contin-
ued ITN effectiveness in areas with pyrethroid resistance
if the barrier effect was an important component of the
ITN mode of action. However, evidence of the effective-
ness of UTNs to reduce malaria transmission is limited:
several observational studies have found UTNs to be
protective against malaria [50], but the only community-
randomized controlled trial of UTNs compared to no
bed nets did not find an epidemiologic benefit, although
there was a reduction in blood feeding [51,52]. In this
study, there was no significant difference in the inci-
dence of malaria between children using UTNs com-
pared to children not using bed nets, but because UTNs
were present in the study community prior to the start
of the study, the integrity of their barrier may have been
reduced through acquisition of holes.
There are other data to suggest that ITNs provide more
than just a physical barrier to malaria transmission in areas
with resistant mosquitoes. A recent meta-analysis of the
entomologic impacts of pyrethroid resistance found that
ITNs were significantly more effective at reducing blood
feeding, inducing exophily and killing mosquitoes than
UTNs despite pyrethroid resistance [20]. This review found
that significant heterogeneity in methods and results across
the studies evaluated made it impossible to determine
whether ITN effectiveness was affected by the level of in-
secticide resistance, but in conjunction with the results of
this study, it appears reasonable to conclude that the in-
secticide on ITNs continues to exert a beneficial effect
even when a significant degree of pyrethroid resistance is
present [20]. Whether the beneficial effect could have been
larger in the absence of pyrethroid resistance is not clear.
This is the first study to show that ITNs continue to pre-
vent malaria infections in an area where pyrethroid-resistant
An. funestus is the dominant vector. As the clearest example
to date of operational failure of insecticide-based vector
control was in South Africa after An. funestus became meta-
bolically resistant to the pyrethroids used in the IRS
programme in the late 1990s [10], the results from this study
hint at potential differences in the impact of insecticideresistance on ITNs and IRS. As vector control interven-
tions, ITNs and IRS both deter mosquitoes from enter-
ing houses, induce exophily and kill mosquitoes that
come into contact with the insecticide. However, ITNs
also act as baited traps, luring mosquitoes to the insecti-
cide with vapour trails of human body gasses [53], and
there are differences between ITNs and IRS in terms of
the concentration of insecticide used and the duration
of the insecticide that might affect results. It is conceiv-
able that these differences could mitigate the impact of
insecticide resistance on ITNs but not IRS. Alternatively,
it is possible that the failure of IRS in South Africa was
not only due to insecticide resistance: increases in malaria
parasite resistance to the first-line anti-malarial treatment
(sulphadoxine-pyrimethamine) occurred around the same
time and may have played a role in the resurgence of cases
[54]. Unfortunately, the available data are not sufficient to
clarify the situation.
A weakness in all studies of insecticide resistance and
malaria transmission is the actual measurement of resist-
ance. WHO recommends measurement of phenotypic re-
sistance through standardized WHO tube assays or the
CDC bottle assay [32]. Both tests measure mosquito mor-
tality after a period of exposure to insecticide. It is recom-
mended to use recently emerged, non-blood fed, adult
female mosquitoes to standardize comparisons over time
and between sites. However, results from these laboratory
assays may not be generalizable to older mosquitoes with
infective sporozoites. As they age, mosquitoes may lose the
oxidase or esterase enzymes responsible for detoxifying in-
secticides and become more susceptible to insecticides
than younger mosquitoes [55]. As a result, phenotypic as-
says of recently emerged mosquitoes may overestimate the
degree of resistance in the epidemiologic important vec-
tors. However, a more recent study suggests that blood
meals cause oxidative stress in resistant mosquitoes that
may maintain resistance within a mosquito throughout its
life [56]. Due to the low vector density in the area, it was
not possible to compare phenotypic resistance assays in
wild-caught and recently emerged mosquitoes contempor-
aneously to determine whether results differed, but this is
an area for future exploration.
Aside from the issue of whether existing assays accur-
ately measure the resistance of the mosquitoes respon-
sible for transmitting malaria, it is not clear whether
there is a threshold at which resistance may begin to
have an epidemiologic impact. Strode and colleagues
classified resistance levels into low, medium and high
based on phenotypic assays and prevalence of kdr; al-
though this somewhat arbitrary classification system was
used in this analysis, it is not based on any epidemio-
logic or entomologic outcomes [20]. It is conceivable
that the level of resistance measured in this study is not
severe enough to show important epidemiologic effects.
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there will continue to be a need to monitor the impact
of resistance on epidemiologic outcomes until and un-
less, new insecticides or technologies reduce the depend-
ence of ITNs on pyrethroids.
This study had several important limitations. Resistance
among mosquito vectors had already occurred in this area
so no comparison with ITNs under conditions of full vector
susceptibility in this population could be made. ITN use in
this population was significantly higher than anticipated, de-
creasing the precision of the protective effectiveness esti-
mate, and potentially limiting the generalizability of the
study results to other areas. The ITNs used in this study
were new at the start, and it is possible that effectiveness
will decline as bed nets degrade physically. To examine this
possibility, the study was extended by an additional nine
months; results are being analysed and will be published
soon. Use of RDTs for malaria diagnosis during the monthly
and sick visits, rather than the gold standard of microscopy,
was necessary given the extremely high number of encoun-
ters with study participants where malaria infection was
measured; but RDTs may pick up treated infections that still
have persistent antigen. This problem was assessed by vary-
ing the interval for determining whether consecutive posi-
tive RDT results were independent, and did not find any
difference in interpretation of results.
This study had several strengths, including that it was
designed prospectively to answer the question of ITN ef-
fectiveness in an area with significant pyrethroid resistance,
rather than conceived as a secondary data analysis. A fixed
cohort with a high follow-up rate was observed, and ITN
use was evaluated frequently over the course of the study
with two surveys to examine the reliability of caregiver re-
port of ITN use. Both active and passive surveillance were
combined to try to capture all malaria infections, both
symptomatic and asymptomatic, and all infections were
parasitologically confirmed. Potential confounders were
carefully measured and included in the final model, includ-
ing estimates of malaria exposure and measures of ITN
density that may cause a community effect. A recent re-
view lamented the lack of concomitant measures of insecti-
cide resistance in other studies of ITNs and pyrethroid
resistance [20]; this study collected information before and
during the study to ensure that insecticide resistance mea-
surements were characteristic of the vector species trans-
mitting malaria in the same time and place as the study
participants, with the caveat that only recently emerged
mosquitoes were evaluated. Additionally, the mechanism
of insecticide resistance underpinning the phenotypic re-
sults was identified.
Conclusion
ITNs continue to protect children from malaria in an
area of Malawi with very high reported ITN use, moderateinsecticide resistance and high rates of malaria transmis-
sion, annually preventing nine cases of malaria for every
ten children protected. Based on these findings, national
malaria control programmes should continue to procure
and distribute ITNs for areas with moderate insecticide re-
sistance. However, as the measures of insecticide resistance
used in this investigation are imperfect, and distribution
and intensity of insecticide resistance could still increase,
these findings do not suggest complacency with the status
quo. Periodic monitoring of the effectiveness of ITNs in
areas of moderate to high pyrethroid resistance should
continue, while research on new insecticides and new tech-
nologies should be pursued urgently to eliminate the pyr-
ethroid Achilles’ heel of ITNs.
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